Skip to content
Open access

Analyzing Gene Expression Patterns in Breast Cancer Subtypes Using Multivariate Analysis of Variance (MANOVA)

Sep 2026 · African journal of mathematics and statistics studies · 0 citations · 22 references

Abstract

Aims: This study investigated the expression patterns of five crucial genes BRCA1, PALB2, CDK1, CDH1, and CHEK2 across breast cancer subtypes using Multivariate Analysis of Variance (MANOVA). Study Design: A quantitative research design based on MANOVA was employed using gene expression data from 1,139 breast cancer patients representing multiple subtypes. Place and Duration of Study: The study utilized secondary genomic data obtained from publicly available breast cancer databases and was conducted over a six-month period. Methodology: Preliminary diagnostic tests assessed normality, multicollinearity, and multivariate outliers. Shapiro–Wilk tests indicated approximate normality, VIF values below 5 confirmed the absence of multicollinearity, and Mahalanobis distance showed no significant outliers (12.68 < 20.515). Although Levene’s and Box’s M tests indicated heterogeneity of variances and covariance matrices (p < 0.001), Pillai’s trace was adopted due to its robustness. Univariate analyses and Scheffe post hoc tests were subsequently conducted. Results: MANOVA revealed a highly significant overall effect of breast cancer subtype on combined gene expression profiles (Pillai’s Trace = 0.525, F = 48.09, p < 0.001, observed power = 1.000). BRCA1, CDK1, CDH1, and CHEK2 significantly discriminated subtypes (p < 0.001), while PALB2 showed marginal significance (p = 0.003). Luminal A and HER2 demonstrated the strongest gene-specific effects, whereas Luminal B showed the least differentiation. Conclusion: The findings confirm distinct subtype-specific gene expression patterns and demonstrate the effectiveness of MANOVA for genomic studies, highlighting its relevance for precision oncology and targeted breast cancer management.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.